Abner Antonio Murray, MD PhD
@dominicandoc2
👨🏾⚕️Physician scientist 🔬in training | Onc Fellow @unchemeonc vía @umjmhimres | MD PhD @CWRUSOM | @FIU Alum | Past Natl Pres @LMSANational & BOD @SNMA 🇩🇴
Thrilled to be part of @winnawards #WinnCDA24, joining 66 incredible scholars from 51 institutions across the country, all committed to advancing #EquityInResearch through the @DrRobWinn #Diversity in #ClinicalTrials Career Development Award. Together, we’re driving…
Absolutely 👏 phenomenal work by @NikitaBacligMD at #ASCO25 highlighting how the fall of Roe v. Wade is reshaping oncofertility care 🧬⚖️ 💥 62.5% of @NCCN centers reported an ⬆️ in cancer patients pursuing fertility preservation 📉 Yet response rates from states with restricted…
Was an honor to present the findings from our @NCCN Best Practices Committee survey evaluating changes in #oncofertility care at Member Institutions after the overturn of Roe v. Wade. A very early look at this important #AYA issue! @JordynSilvs @beth_karlan #UCLA #ASCO25
So proud of @AsiaOnabanjo for matching into the Men’s Health/Andrology Fellowship at @HenryFordHealth! From groundbreaking research in prosthetic urology to compassionate patient care, she’s already changing the game. Detroit is lucky. 💙 ow.ly/102650WhcKB
Huge congratulations to @LeukDocJZ on a stellar @EHA_Hematology presentation + first-author @JCO_ASCO publication! The Aza/Ven/Revumenib triplet in newly diagnosed older/unfit NPM1m or KMT2Ar #AML delivered: 🧬 ORR 88% | CRc 81% | CR 67% 🔬 100% MRD-negative by flow 🚫 0%…
Thrilled to officially join the 2025–2026 @ASCO Trainee & Early Career Advisory Group (@ASCOTECAG )! 💼🌟 This powerhouse team brings together trainees from across the country united by a shared mission: championing the next generation of oncologists. Grateful for the…
📢 The 🟰 #EQUAL study presented at #ASCO25 by @Florez_Lab is redefining who gets screened for lung 🫁 cancer. Using blood-based EGFR ctDNA testing in Latinx & East/Southeast Asian 🌏 nonsmokers, this trial is paving a path toward equity in early detection. 🧬🩸 🧪 Over 60% of…
Thank you to everyone that came to visit our #EQUAL study poster @ASCO. We are so happy to have had the opportunity to present this amazing study and are grateful for the love and support from everyone for EQUAL. #mobilephlebotomyiskey #LCSM
Important early data from Dr. Anuja Abhyankar @anuja_abhyankar at #ASCO25 🧪🧠 In this single-center cohort study, prophylactic dexamethasone use in CAR T-cell recipients with elevated ferritin/CRP was associated with: 🔻 Lower rates of ≥Grade 3 CRS 🔼 Higher CR (60% vs 30%) 🟣…
📣 Powerful work by @YabdouMD at #ASCO25 exposing a critical reality: eligibility alone isn’t equity. In this real-world study, Black women with HR+/HER2− early breast cancer—eligible for ribociclib per NATALEE—still faced worse RFS, DRFS, and OS compared to White women. ⚖️…
At #ASCO25, @YabdouMD reported Black pts with high-risk HR+/HER2 early breast cancer had higher recurrence risk + worse survival compared w/White pts, underscoring the urgent need to improve outcomes/address disparities. #BCSM
🚨 First-in-human trial alert from #ASCO25! 🧬🧪 Shoutout to my fellow @ASCOTECAG member @FionnualaCrowle for presenting the TPS2696 poster on combining anti–IL-4Rα (dupilumab) with anti–PD-1 (cemiplimab) in resectable early-stage #NSCLC 👏 🔹 Targeting IL-4 signaling—a novel…
A big congrats to my friend and fellow @HemOncFellows at @YaleHemOnc @CostaPhilippos on his ASCO25 poster evaluating olaparib in IDH1/2-mutant chondrosarcomas and solid tumors 🧬📉 Though the results were negative, they speak volumes: 🔹 ORR: 0% 🔹 mPFS: 2.0 mo 🔹 mOS: 4.6 mo 🔹…
🏆 Big congrats to @UNC_Lineberger on winning the 2025 @cityofhope @GoHealio Clinical Innovation Award at #ASCO25 for their game-changing at-home symptom reporting platform! Led by @EthanBasch1 & team @LeakBryantPhD , this digital tool: ✅ Reduced ER visits ✅ Boosted QoL ✅…
More proof our awards are a well kept secret: Found @EthanBasch1 to present the @GoHealio @cityofhope Clinical Innovation award for his work on at-home symptom reporting at @UNC_Lineberger. Thankful a colleague accepted for him; more excited to see it in his hands today!
Incredible work by incoming @hemeoncfellow @duaakanan21 at #ASCO25! 🧠🧬 Her poster highlights a structure-based AI pipeline for identifying novel #NSCLC therapies via FDA-approved & investigational drug repurposing. ✅ Target: USP21, implicated in chemo resistance 🧪 Screened…
Amazing @ASCO poster @duaakanan21!!!
Congrats to Dr. Tracy Rose on presenting results from LCCC1827, a neoadjuvant trial of pembrolizumab ± entinostat in cis-ineligible #MIBC at #ASCO25 🦠🧬 🔍 Key findings in 20 patients: — ✅ pCR: 29%, pRR: 43% in both arms (P vs P+Ent) — ✅ cT0 on TMT: 100% in P alone, 66% with…
Huge congrats to my friend, @HemOncFellows , & fellow @ASCOTECAG member Dr. Fionnuala Crowley (@FionnualaCrowle) on her #ASCO25 poster addressing a critical question in trial equity & supportive care: Can we integrate palliative care earlier for patients in early-phase clinical…
🫧 Huge congrats to Dr. Oyepeju Abioye-Akintola @AbioyeOyepejuMD on a stellar #ASCO25 poster presentation! Her study, “The Bubble Effect,” 🫧 asked bold questions on the power of #SoMe in oncology—and delivered data to match 📲📈 📚 Key takeaways: 🔹 @ASCO tweets and @JCO_ASCO…
